Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Intervalo de año de publicación
1.
Arq Neuropsiquiatr ; 70(9): 727-32, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22990732

RESUMEN

This review intended to describe in a didactic and practical manner the frontotemporosphenoidal craniotomy, which is usually known as pterional craniotomy and constitute the cranial approach mostly utilized in the modern neurosurgery. This is, then, basically a descriptive text, divided according to the main stages involved in this procedure, and describes with details how the authors currently perform this craniotomy.


Asunto(s)
Craneotomía/métodos , Microcirugia/métodos , Disección , Hueso Frontal/cirugía , Humanos , Ilustración Médica , Osteotomía/métodos , Posicionamiento del Paciente/métodos , Hueso Esfenoides/cirugía , Hueso Temporal/cirugía
2.
APMIS ; 120(11): 882-9, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23009112

RESUMEN

TP53 mutations and polymorphisms have been widely related to many cancers as long as these alterations may impair its capacity to induce cell cycle arrest, DNA repair mechanisms, and apoptosis. Although TP53 alterations have been studied in astrocytic tumors, there is a lack of analysis considering specific TP53 mutations and their associations with p53 immunostainning, polymorphisms and their significance among the histological grades. Thus, we analyzed TP53 alterations in exons 2-11, including the codon 72 polymorphism, using DNA sequencing in 96 astrocytic gliomas (18 grade I, 20 grade II, 14 grade III, and 44 grade IV). Also, immunohistochemistry was assessed to evaluate the p53 protein expression. In this study, we found that the higher histological grades were statistically associated with TP53 mutations. Some of these mutations, such as TP53 P98T and TP53 G244S, seemed to be a specific marker for the higher grades, and the TP53 E286K mutation appears to be a World Health Organization grade III-IV progression marker. Also, the TP53 P98T mutation, in exon 4, is very likely to be important on the stabilization of the p53 protein, leading to its immunopositivity and it is potentially associated with the TP53 72Pro/Pro genotype.


Asunto(s)
Astrocitoma/genética , Astrocitoma/patología , Genes p53 , Mutación , Proteína p53 Supresora de Tumor/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Astrocitoma/metabolismo , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/genética , Niño , Preescolar , Codón , ADN de Neoplasias/genética , Exones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo Genético , Análisis de Secuencia de ADN , Proteína p53 Supresora de Tumor/genética , Adulto Joven
3.
Arq. neuropsiquiatr ; 70(9): 727-732, Sept. 2012. ilus
Artículo en Inglés | LILACS | ID: lil-649309

RESUMEN

This review intended to describe in a didactic and practical manner the frontotemporosphenoidal craniotomy, which is usually known as pterional craniotomy and constitute the cranial approach mostly utilized in the modern neurosurgery. This is, then, basically a descriptive text, divided according to the main stages involved in this procedure, and describes with details how the authors currently perform this craniotomy.


A presente revisão visou descrever de forma didática e prática a realização da craniotomia frontotemporoesfenoidal, usualmente denominada pterional, que constitui a craniotomia mais utilizada na prática neurocirúrgica atual. Trata-se, portanto, de um texto fundamentalmente descritivo, dividido conforme as principais etapas envolvidas na realização desse procedimento, que mostra com detalhes a técnica utilizada atualmente pelo presente grupo de autores.


Asunto(s)
Humanos , Craneotomía/métodos , Microcirugia/métodos , Disección , Hueso Frontal/cirugía , Ilustración Médica , Osteotomía/métodos , Posicionamiento del Paciente/métodos , Hueso Esfenoides/cirugía , Hueso Temporal/cirugía
4.
BMC Gastroenterol ; 9: 55, 2009 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-19619279

RESUMEN

BACKGROUND: This study evaluates the existence of numerical alterations of chromosome 17 and TP53 gene deletion in gastric adenocarcinoma. The p53 protein expression was also evaluated, as well as, possible associations with clinicopathological characteristics. METHODS: Dual-color fluorescence in situ hybridization and immunostaining were performed in twenty gastric cancer samples of individuals from Northern Brazil. RESULTS: Deletion of TP53 was found in all samples. TP53 was inactivated mainly by single allelic deletion, varying to 7-39% of cells/case. Aneusomy of chromosome 17 was observed in 85% of cases. Chromosome 17 monosomy and gain were both observed in about half of cases. Cells with gain of chromosome 17 frequently presented TP53 deletion. The frequency of cells with two chr17 and one TP53 signals observed was higher in diffuse than in intestinal-type GC. Immunoreactivity of p53 was found only in intestinal-type samples. The frequency of cells with two chr17 and two TP53 signals found was higher in samples with positive p53 expression than in negative cases in intestinal-type GC. CONCLUSION: We suggest that TP53 deletion and chromosome 17 aneusomy is a common event in GC and other TP53 alterations, as mutation, may be implicated in the distinct carcinogenesis process of diffuse and intestinal types.


Asunto(s)
Adenocarcinoma/genética , Aberraciones Cromosómicas , Cromosomas Humanos Par 17/genética , Eliminación de Gen , Regulación Neoplásica de la Expresión Génica/genética , Neoplasias Gástricas/genética , Proteína p53 Supresora de Tumor/genética , Adenocarcinoma/patología , Adulto , Anciano , Alelos , Brasil , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Estudios de Casos y Controles , Femenino , Humanos , Hibridación Fluorescente in Situ , Pérdida de Heterocigocidad/genética , Masculino , Persona de Mediana Edad , Neoplasias Gástricas/patología
5.
Neuropathology ; 26(6): 519-27, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17203587

RESUMEN

Astrocytomas represent the most frequent primary tumors of the central nervous system. Recently, the determination of the proliferative index of astrocytic tumors by different methods has been proposed as a valuable tool for tumor grading and also as a prognostic marker. The aim of the present study was to evaluate the expression of cell proliferation-related proteins in human astrocytic tumors of different histopathological grades (WHO). An immunohistochemical study of the Ki-67, Topoisomerase IIalpha (Topo IIalpha) and c-MYC proteins using the avidin-biotin-peroxidase method was performed in 55 astrocytomas (13 grade I, 14 grade II, 7 grade III and 21 grade IV) and five samples of non-tumor brain tissue (control group). Ki-67, Topo IIalpha and c-MYC positive indices tended to increase according to malignant progression, were absent in non-tumor brain tissue and showed maximum values in high-grade astrocytomas (III and IV). A gradual increase in Ki-67 antigen expression was observed in agreement with mitotic index and histopathological classification. The same was not observed for Topo IIalpha and c-MYC. Ki-67 antigen detection in more than 8.0% of the tumor cells distinguished astrocytoma grade IV, while a labeling index between 1.5 and 8.0% characterized astrocytomas grade III and values below 1.5% discriminated low-grade tumors (I and II). These results indicate that Topo IIalpha and c-MYC expression is associated with cell proliferation in astrocytomas, although not in an exclusive way. Moreover, Ki-67 antigen was found to be the best marker of cellular proliferation, and its expression predicts the grade of astrocytic tumors.


Asunto(s)
Astrocitoma/metabolismo , Astrocitoma/patología , Biomarcadores de Tumor/metabolismo , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antígenos de Neoplasias/metabolismo , División Celular , Niño , Preescolar , ADN-Topoisomerasas de Tipo II/metabolismo , Proteínas de Unión al ADN/metabolismo , Femenino , Glioblastoma/metabolismo , Glioblastoma/patología , Humanos , Inmunohistoquímica , Lactante , Antígeno Ki-67/metabolismo , Masculino , Persona de Mediana Edad , Pronóstico , Proteínas Proto-Oncogénicas c-myc/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...